Hematology 2025_ Event Postponement

This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.

Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.

For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.

Hematology and Pharma Industry

Hematology is the branch of medicine that deals with blood and bone marrow abnormalities, such as anaemia, coagulation problems, and malignancies like leukaemia. Pharmacometrics and quantitative systems pharmacology (QSP) are increasingly being employed in model-informed drug discovery and development (MID3) of new haematological medications, as well as clinical tools to improve the efficacy of existing therapies. More than a century ago, the linkages between quantitative pharmacology and haematology were identified. Since it is often predicted to be enhanced over the years and years, the entire market for haematological medications is at a high point. From 2015 to 2021, the haematology sedate and expressive market is expected to grow at a rate of 7.5 percent, according to the overall market master.